AV
Avant Brands Inc.
AVTBF · OTC
$0.40 +3.43% (+$0.01)
1M -16.40%
Market Cap $8.62M
P/E Ratio -
Div. Yield -
ROE 49.96%
Bulios Fair Price
$0.59
46.7% upside
Current Price
$0.4
Undervalued Fair Value Overvalued
According to Bulios Fair Price, AVTBF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
4/9Valuation
100 /100
Cheap P/S 0.21x
P/B 0.41x
P/FCF 1.78x
Growth
78 /100
Growing Rev. growth 21.18%
Book val. growth 17.38%
EPS growth N/A
Profitability
22 /100
Weak Gross margin 7.79%
Net margin 28.47%
Op. margin 18.14%
Quality
11 /100
Poor ROIC 20.93%
ROE 49.96%
ROA 25.29%
Debt
45 /100
Moderate Debt/Equity 0.67x
Current ratio 1.22x
Int. coverage -5.99x
Stability
28 /100
Unstable Beta 1.45x
Rev. volatility 19.33%
EPS volatility 192.07%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about AVTBF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Norton Singhavon
Employees
180
Headquarters
Kelowna
Upcoming events
15 OCT
Earnings
Upcoming earnings report